- Home
- INTA vs VKTX Comparison
INTA vs VKTX Comparison
Compare INTA & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTA
- VKTX
- Stock Information
- Founded
- INTA 2000
- VKTX 2012
- Country
- INTA United States
- VKTX United States
- Employees
- INTA N/A
- VKTX N/A
- Industry
- INTA Computer Software: Prepackaged Software
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- INTA Technology
- VKTX Health Care
- Exchange
- INTA Nasdaq
- VKTX Nasdaq
- Market Cap
- INTA 4.4B
- VKTX 4.6B
- IPO Year
- INTA 2021
- VKTX 2015
- Fundamental
- Price
- INTA $64.86
- VKTX $42.25
- Analyst Decision
- INTA Strong Buy
- VKTX Strong Buy
- Analyst Count
- INTA 12
- VKTX 12
- Target Price
- INTA $60.91
- VKTX $106.75
- AVG Volume (30 Days)
- INTA 705.5K
- VKTX 3.7M
- Earning Date
- INTA 02-04-2025
- VKTX 02-05-2025
- Dividend Yield
- INTA N/A
- VKTX N/A
- EPS Growth
- INTA N/A
- VKTX N/A
- EPS
- INTA N/A
- VKTX N/A
- Revenue
- INTA $447,753,000.00
- VKTX N/A
- Revenue This Year
- INTA $17.78
- VKTX N/A
- Revenue Next Year
- INTA $14.91
- VKTX N/A
- P/E Ratio
- INTA N/A
- VKTX N/A
- Revenue Growth
- INTA 20.07
- VKTX N/A
- 52 Week Low
- INTA $30.36
- VKTX $17.23
- 52 Week High
- INTA $71.34
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- INTA 51.07
- VKTX 33.93
- Support Level
- INTA $63.61
- VKTX $37.80
- Resistance Level
- INTA $71.34
- VKTX $48.55
- Average True Range (ATR)
- INTA 2.16
- VKTX 2.54
- MACD
- INTA -0.85
- VKTX -0.45
- Stochastic Oscillator
- INTA 4.74
- VKTX 30.11
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.